The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99-Reference-Cited by-同舟云学术

The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99

Published:2009-08 Issue:4 Volume:146 Page:424-436
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Mitchell Christopher,Payne Jeanette,Wade Rachel,Vora Ajay,Kinsey Sally,Richards Sue,Eden Tim

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07769.x/fullpdf

Reference22 articles.

1. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children’s Cancer Group;Bostrom;Blood,2003

2. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X;Chessells;Lancet,1995

3. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials;Chessells;British Journal of Haematology,1995

4. Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from UK Medical Research Council trials UKALL X and UKALL XI;Chessells;British Journal of Haematology,2002

5. Results of the Medical Research Council Leukaemia Trial UKALL VIII (Report to the MRC on behalf of the Working Party on Leukaemia in Childhood);Eden;British Journal of Haematology,1991

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment outcomes in childhood acute lymphoblastic leukemia: 40-year experience from a single tertiary center in Thailand;Pediatric Hematology and Oncology;2023-03-20

2. Early post‐induction augmented therapy improves outcome in children and adolescents with T ‐cell acute lymphoblastic leukemia;Cancer Reports;2022-08-12

3. Excess morbidity and mortality among survivors of childhood acute lymphoblastic leukaemia: 25 years of follow-up from the United Kingdom Childhood Cancer Study (UKCCS) population-based matched cohort;BMJ Open;2022-03

4. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials;The Lancet Haematology;2021-11

5. Excess morbidity and mortality among survivors of childhood acute lymphoblastic leukaemia: 25 years of follow-up from the United Kingdom Childhood Cancer Study (UKCCS);2021-07-29